Johnson IM, Ilyas R, McCullough K, Al-Kali A, Alkhateeb HB, Begna KH, Mangaonkar A, Saliba A, Litzow MR, Hogan W, Shah M, Patnaik MM, Pardanani A, Tefferi A, Gangat N. Molecular predictors of response and survival in patients with relapsed/refractory acute myeloid leukemia following venetoclax plus hypomethylating agent therapy. haematol [Internet]. 2020Sep.10 [cited 2025Mar.6];. Available from: https://haematologica.org/article/view/11956